About the GRACE Initiative

The GRACE Initiative is being spearheaded by Outcome Sciences (Outcome) with seed funding from the National Pharmaceutical Council. Outcome is the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes. The National Pharmaceutical Council's (NPC) overarching mission is to sponsor and conduct scientific analyses of the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation. NPC was established in 1953 and is supported by approximately 20 of the nation's major research-based pharmaceutical companies. GRACE contributors are from academic, government, and private sectors from around the world and represent many different perspectives on comparative effectiveness.